7Baggers
 itos sec filings - iteos therapeutics, inc. 10-k, 10-q, 8-k forms  Stock Titan Tue, 16 Sep 2025 08:06:47 GMT
 published on: 2025-09-06 20:26:58  classian.co.kr Sat, 06 Sep 2025 11:26:58 GMT
 nuveen llc buys new shares in iteos therapeutics, inc. $itos  MarketBeat Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 08:55:28  Newser Wed, 03 Sep 2025 13:55:28 GMT
 published on: 2025-09-03 08:55:28  Newser Sun, 31 Aug 2025 03:17:09 GMT
 published on: 2025-08-30 20:12:59  Newser Sun, 31 Aug 2025 01:12:59 GMT
 published on: 2025-08-29 12:49:12  Newser Fri, 29 Aug 2025 17:49:12 GMT
 iteos therapeutics, inc.(nasdaqgm: itos) dropped from s&p tmi index  MarketScreener Fri, 29 Aug 2025 01:21:35 GMT
 published on: 2025-08-28 12:09:19  Newser Thu, 28 Aug 2025 17:09:19 GMT
 published on: 2025-08-28 09:45:09  Newser Thu, 28 Aug 2025 14:45:09 GMT

iTeos Therapeutics, Inc
(NASDAQ:ITOS) 

ITOS stock logo

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2a receptor that is an open-label Phase 1/2a...

Founded: 2012
Full Time Employees: 55
CEO: Michel Detheux  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends